Novo Nordisk has planted another seed to fuel the blossoming of its obesity business, inking an $812 million deal with Deep ...

Court filings give insight into why shooting suspect Louis Mangione might have targeted the UnitedHealthcare executive: "It checks every box." In other news: Hospital construction trends include AI; ...

In the shadow of President Trump's efforts to lower drug prices, the Medicare drug price negotiation process that began in ...

Novo Nordisk had a head start ... and some have refused to cover them. In most cases, Medicare will not pay for the drugs to treat obesity. The Trump administration recently rejected a Biden ...

Meanwhile, current GLP-1 offerings like Ozempic and Wegovy are also subject to the next round of Medicare drug pricing negotiations in the U.S. “Considering the recent market challenges, the share ...

Novo Nordisk also markets Rybelsus (semaglutide ... Rybelsus therapy has restrictions on food and water intake. Earlier this month, Medicare announced that it will not cover costly weight-loss ...

That question is at the heart of an unusual challenge that the pharma company Novo Nordisk is pursuing against ... have major ramifications for the Medicare drug price negotiation program, a ...

That question is at the heart of an unusual challenge that the pharma company Novo Nordisk is pursuing against ... have major ramifications for the Medicare drug price negotiation program, a ...

PITTSBURGH (CN) — Bashing a Biden-era law that gives Medicare the power to directly negotiate the price of certain high-cost prescription drugs, an attorney for the pharmaceutical giant Novo Nordisk ...

The Centers for Medicare and Medicaid Services issued ... $620 and maintaining our DKK 640/$89 fair value estimate for Novo Nordisk. We had not assumed this proposed rule would pass, and we ...

However, a spokesperson for Novo Nordisk implied the Danish drugmaker plans to continue lobbying for expanded Medicare coverage of GLP-1s. Novo Nordisk is “committed to ensuring that people ...

Medicare enrollees can receive coverage for ... to the FDA-approved versions of the drugs and this new program from Novo Nordisk appears to cater to individuals who were accustomed to getting ...